newsfilter
← Latest News
ClinicalTrials.gov·

Adaptive Stereotactic Body Radiation Therapy to the Prostate and Pelvic Nodes With Simultaneous Integrated Boost to the MR-detected Nodule for Patients With High-risk and Unfavorable Intermediate-risk Prostate Cancer - NCT05628363

Rate of acute grade ≥3 GI and GU adverse events, Changes in patient-reported quality of life as measured by EPIC-26, Changes in global function as measured by EQ-5D-5L, (and 16 more...)